Skip to main content

Cooper Financial Group

SEC CIK
0001751581
Latest filing
Jul 8, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Cooper Financial Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q1 2023)
0
Sold out in Q1 2023
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q3 2022
Holdings of HALO by Cooper Financial Group, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20230$00.0%−7,378−100.0%Sold outHolders
Q4 20227,378$419.8K0.1%+436+6.3%AddedHolders
Q3 20226,942$274.0K0.1%+6,942NewHolders